Skip to content
Home/Companies/Biotech/Emergence Therapeutics

Emergence Therapeutics

Biotech·Germany·Exited 2023·Held 4yr
Entry
2019
Hold
4yr
Exit
2023

Who owns Emergence Therapeutics?

Emergence Therapeutics was owned by Gruenderfonds Ruhr through Gruenderfonds Ruhr I (2017 vintage) from 2019 to 2023, exited via Trade Sale. Across its history, Emergence Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Gruenderfonds Ruhr
Most recent investor
Gruenderfonds Ruhr
Gruenderfonds Ruhr I · 2017 · VC
3 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2023.
  • ·Average hold across 3 realized cycles: 4 years.

Ownership history

3 ownership periods · co-invest detected

Exited
Last exited in 2023 to .
Co-invest · 3 holders · 2019 · 2023
NRW.BANK
NRW.BANKExited 2023
2019 · 2023(4yr) · NRW.Venture · 2006 · VC
Trade Sale · to
MOIC
–
High-Tech Gruenderfonds (HTGF)
High-Tech Gruenderfonds (HTGF)Exited 2023
2019 · 2023(4yr) · HTGF III · 2017 · VC
Trade Sale · to
MOIC
–
Gruenderfonds Ruhr
Gruenderfonds RuhrExited 2023
2019 · 2023(4yr) · Gruenderfonds Ruhr I · 2017 · VC
Trade Sale · to
MOIC
–

More from Gruenderfonds Ruhr I

Other portfolio companies in the same fund.

Lidrotec
Active
IndustrialsGermany· 2022
Spherity
Spherity
Active
CybersecurityGermany· 2022
VMRay
VMRay
Active
CybersecurityGermany· 2022
Advosense
Advosense
Active
MedTechGermany· 2020
Masterplan
Masterplan
Exited 2025
SoftwareGermany· 2020
to
Abalos Therapeutics
Active
BiotechGermany· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Emergence Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Emergence Therapeutics?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Emergence Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue